Special Approval for Emergency on Remdesivir for COVID-19
Japan (National)
Issuing Authority: Pharmaceutical and Medical Devices Agency
Type: Law/Policy Document
Issued: May 8, 2020
DownloadDocument
Document
More tagged Access to medicines and intellectual property, State of emergency/public health emergency
Guidelines on distribution of medical oxygen amid rising Covid-19 cases
Regulation of the Minister of Education and Science of 28 January 2022 amending the regulation on the temporary limitation of the functioning of units of the education system in connection with preventing, counteracting and combating COVID-19
Regulation of the Minister of Education and Science of 11 February 2022 amending the regulation on the temporary limitation of the functioning of units of the education system in connection with preventing, counteracting and combating COVID-19
Data from Japan
Cumulative Cases
24,654,770
Cumulative Deaths
49,434
WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. Available online: https://covid19.who.int/ (last cited: 2022-11-30).